Skip to content

A randomized controlled study on the treatment of refractory atlantoaxial dislocation

A randomized controlled study on the treatment of refractory atlantoaxial dislocation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070563
Enrollment
Unknown
Registered
2023-04-17
Start date
2023-04-10
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory atlantoaxial dislocation

Interventions

Anterior and posterior treatment strategy group:Implement anterior oral release and posterior fixation fusion technology for reduction
Posterior treatment strategy group:Posterior release and internal fixation

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age range from 0 to 80 years old, regardless of gender; 2) According to preoperative imaging and skull traction evaluation with a weight of 1/6 after anesthesia, patients diagnosed as refractory atlantoaxial dislocation were treated surgically; 3) Sign an informed consent form; 4) Patients who can choose between simple posterior reduction and fixation or combined anterior and posterior reduction and fixation.

Exclusion criteria

Exclusion criteria: 1) Atlantoaxial dislocation without surgical treatment 2) Patients who refuse to participate in this project

Design outcomes

Primary

MeasureTime frame
Adverse event occurrence rate;

Secondary

MeasureTime frame
Reduction rate;improvement rate of neurological function;fusion rate;

Countries

China

Contacts

Public ContactShenglin Wang

Peking University Third Hospital

pkuwsl@126.com+86 13501380281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026